Click for best price
Next Generation Cancer Diagnostics Market Size, Share 2023
| Market size in 2022 |
US$ 6377.6 million
|
Forecast Market size by 2029 |
US$ 19960 million
|
| Growth Rate |
CAGR of 17.7% |
Number of Pages |
102 Pages |
This report aims to provide a comprehensive presentation of the global market for Next Generation Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Cancer Diagnostics. This report contains market size and forecasts of Next Generation Cancer Diagnostics in global, including the following market information:
Global Next Generation Cancer Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Next Generation Cancer Diagnostics market was valued at US$ 6377.6 million in 2022 and is projected to reach US$ 19960 million by 2029, at a CAGR of 17.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Next Generation Sequencing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Next Generation Cancer Diagnostics include Cepheid, Koninklijke Philips N.V, F. Hoffmann-La Roche Ltd, Qiagen, Novartis AG, Abbott, Thermo Fisher Scientific, Opko Health and Myriad Genetics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Next Generation Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next Generation Cancer Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Global Next Generation Cancer Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Next Generation Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Next Generation Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Cancer Diagnostics, market overview.
Chapter 2: Global Next Generation Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Next Generation Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Next Generation Cancer Diagnostics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 6377.6 million
|
| Forecast Market size by 2029 |
US$ 19960 million
|
| Growth Rate |
CAGR of 17.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Next Generation Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Cancer Diagnostics Overall Market Size
2.1 Global Next Generation Cancer Diagnostics Market Size: 2022 VS 2029
2.2 Global Next Generation Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Cancer Diagnostics Players in Global Market
3.2 Top Global Next Generation Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Next Generation Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Next Generation Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Cancer Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Next Generation Sequencing
4.1.3 qPCR & Multiplexing
4.1.4 DNA Microarrays
4.1.5 Others
4.2 By Type - Global Next Generation Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Next Generation Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Next Generation Cancer Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Cancer Diagnostics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Next Generation Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Next Generation Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Next Generation Cancer Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Next Generation Cancer Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Next Generation Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Next Generation Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Next Generation Cancer Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Next Generation Cancer Diagnostics Revenue, 2018-2029
6.3.2 US Next Generation Cancer Diagnostics Market Size, 2018-2029
6.3.3 Canada Next Generation Cancer Diagnostics Market Size, 2018-2029
6.3.4 Mexico Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Next Generation Cancer Diagnostics Revenue, 2018-2029
6.4.2 Germany Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.3 France Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.4 U.K. Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.5 Italy Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.6 Russia Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.8 Benelux Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Next Generation Cancer Diagnostics Revenue, 2018-2029
6.5.2 China Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.3 Japan Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.4 South Korea Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.6 India Next Generation Cancer Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Next Generation Cancer Diagnostics Revenue, 2018-2029
6.6.2 Brazil Next Generation Cancer Diagnostics Market Size, 2018-2029
6.6.3 Argentina Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue, 2018-2029
6.7.2 Turkey Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7.3 Israel Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7.5 UAE Next Generation Cancer Diagnostics Market Size, 2018-2029
7 Next Generation Cancer Diagnostics Companies Profiles
7.1 Cepheid
7.1.1 Cepheid Company Summary
7.1.2 Cepheid Business Overview
7.1.3 Cepheid Next Generation Cancer Diagnostics Major Product Offerings
7.1.4 Cepheid Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Cepheid Key News & Latest Developments
7.2 Koninklijke Philips N.V
7.2.1 Koninklijke Philips N.V Company Summary
7.2.2 Koninklijke Philips N.V Business Overview
7.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Major Product Offerings
7.2.4 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Koninklijke Philips N.V Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 Qiagen
7.4.1 Qiagen Company Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Next Generation Cancer Diagnostics Major Product Offerings
7.4.4 Qiagen Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Qiagen Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Next Generation Cancer Diagnostics Major Product Offerings
7.5.4 Novartis AG Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Next Generation Cancer Diagnostics Major Product Offerings
7.6.4 Abbott Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Major Product Offerings
7.7.4 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Opko Health
7.8.1 Opko Health Company Summary
7.8.2 Opko Health Business Overview
7.8.3 Opko Health Next Generation Cancer Diagnostics Major Product Offerings
7.8.4 Opko Health Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Opko Health Key News & Latest Developments
7.9 Myriad Genetics
7.9.1 Myriad Genetics Company Summary
7.9.2 Myriad Genetics Business Overview
7.9.3 Myriad Genetics Next Generation Cancer Diagnostics Major Product Offerings
7.9.4 Myriad Genetics Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Myriad Genetics Key News & Latest Developments
7.10 Agilent Technologies
7.10.1 Agilent Technologies Company Summary
7.10.2 Agilent Technologies Business Overview
7.10.3 Agilent Technologies Next Generation Cancer Diagnostics Major Product Offerings
7.10.4 Agilent Technologies Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Agilent Technologies Key News & Latest Developments
7.11 GE Healthcare
7.11.1 GE Healthcare Company Summary
7.11.2 GE Healthcare Business Overview
7.11.3 GE Healthcare Next Generation Cancer Diagnostics Major Product Offerings
7.11.4 GE Healthcare Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.11.5 GE Healthcare Key News & Latest Developments
7.12 PerkinElmer
7.12.1 PerkinElmer Company Summary
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Next Generation Cancer Diagnostics Major Product Offerings
7.12.4 PerkinElmer Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.12.5 PerkinElmer Key News & Latest Developments
7.13 Genomic Health
7.13.1 Genomic Health Company Summary
7.13.2 Genomic Health Business Overview
7.13.3 Genomic Health Next Generation Cancer Diagnostics Major Product Offerings
7.13.4 Genomic Health Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Genomic Health Key News & Latest Developments
7.14 Illumina
7.14.1 Illumina Company Summary
7.14.2 Illumina Business Overview
7.14.3 Illumina Next Generation Cancer Diagnostics Major Product Offerings
7.14.4 Illumina Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.14.5 Illumina Key News & Latest Developments
7.15 Hologic
7.15.1 Hologic Company Summary
7.15.2 Hologic Business Overview
7.15.3 Hologic Next Generation Cancer Diagnostics Major Product Offerings
7.15.4 Hologic Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.15.5 Hologic Key News & Latest Developments
7.16 Almac Group
7.16.1 Almac Group Company Summary
7.16.2 Almac Group Business Overview
7.16.3 Almac Group Next Generation Cancer Diagnostics Major Product Offerings
7.16.4 Almac Group Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.16.5 Almac Group Key News & Latest Developments
7.17 Janssen Global Services
7.17.1 Janssen Global Services Company Summary
7.17.2 Janssen Global Services Business Overview
7.17.3 Janssen Global Services Next Generation Cancer Diagnostics Major Product Offerings
7.17.4 Janssen Global Services Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.17.5 Janssen Global Services Key News & Latest Developments
7.18 Sysmex Corporation
7.18.1 Sysmex Corporation Company Summary
7.18.2 Sysmex Corporation Business Overview
7.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Major Product Offerings
7.18.4 Sysmex Corporation Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.18.5 Sysmex Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Next Generation Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Next Generation Cancer Diagnostics Market Drivers in Global Market
Table 3. Next Generation Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Next Generation Cancer Diagnostics in Global Market
Table 5. Top Next Generation Cancer Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Next Generation Cancer Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Next Generation Cancer Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Next Generation Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Next Generation Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Next Generation Cancer Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Next Generation Cancer Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Cepheid Company Summary
Table 31. Cepheid Next Generation Cancer Diagnostics Product Offerings
Table 32. Cepheid Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Cepheid Key News & Latest Developments
Table 34. Koninklijke Philips N.V Company Summary
Table 35. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Offerings
Table 36. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Koninklijke Philips N.V Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd Company Summary
Table 39. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Offerings
Table 40. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 42. Qiagen Company Summary
Table 43. Qiagen Next Generation Cancer Diagnostics Product Offerings
Table 44. Qiagen Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Qiagen Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Next Generation Cancer Diagnostics Product Offerings
Table 48. Novartis AG Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Next Generation Cancer Diagnostics Product Offerings
Table 52. Abbott Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Abbott Key News & Latest Developments
Table 54. Thermo Fisher Scientific Company Summary
Table 55. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Offerings
Table 56. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Thermo Fisher Scientific Key News & Latest Developments
Table 58. Opko Health Company Summary
Table 59. Opko Health Next Generation Cancer Diagnostics Product Offerings
Table 60. Opko Health Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Opko Health Key News & Latest Developments
Table 62. Myriad Genetics Company Summary
Table 63. Myriad Genetics Next Generation Cancer Diagnostics Product Offerings
Table 64. Myriad Genetics Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Myriad Genetics Key News & Latest Developments
Table 66. Agilent Technologies Company Summary
Table 67. Agilent Technologies Next Generation Cancer Diagnostics Product Offerings
Table 68. Agilent Technologies Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Agilent Technologies Key News & Latest Developments
Table 70. GE Healthcare Company Summary
Table 71. GE Healthcare Next Generation Cancer Diagnostics Product Offerings
Table 72. GE Healthcare Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. GE Healthcare Key News & Latest Developments
Table 74. PerkinElmer Company Summary
Table 75. PerkinElmer Next Generation Cancer Diagnostics Product Offerings
Table 76. PerkinElmer Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. PerkinElmer Key News & Latest Developments
Table 78. Genomic Health Company Summary
Table 79. Genomic Health Next Generation Cancer Diagnostics Product Offerings
Table 80. Genomic Health Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. Genomic Health Key News & Latest Developments
Table 82. Illumina Company Summary
Table 83. Illumina Next Generation Cancer Diagnostics Product Offerings
Table 84. Illumina Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 85. Illumina Key News & Latest Developments
Table 86. Hologic Company Summary
Table 87. Hologic Next Generation Cancer Diagnostics Product Offerings
Table 88. Hologic Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 89. Hologic Key News & Latest Developments
Table 90. Almac Group Company Summary
Table 91. Almac Group Next Generation Cancer Diagnostics Product Offerings
Table 92. Almac Group Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 93. Almac Group Key News & Latest Developments
Table 94. Janssen Global Services Company Summary
Table 95. Janssen Global Services Next Generation Cancer Diagnostics Product Offerings
Table 96. Janssen Global Services Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 97. Janssen Global Services Key News & Latest Developments
Table 98. Sysmex Corporation Company Summary
Table 99. Sysmex Corporation Next Generation Cancer Diagnostics Product Offerings
Table 100. Sysmex Corporation Next Generation Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 101. Sysmex Corporation Key News & Latest Developments
List of Figures
Figure 1. Next Generation Cancer Diagnostics Segment by Type in 2022
Figure 2. Next Generation Cancer Diagnostics Segment by Application in 2022
Figure 3. Global Next Generation Cancer Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Next Generation Cancer Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Next Generation Cancer Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Next Generation Cancer Diagnostics Revenue in 2022
Figure 8. By Type - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Cepheid Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Qiagen Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbott Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Opko Health Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Myriad Genetics Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Agilent Technologies Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GE Healthcare Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. PerkinElmer Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Genomic Health Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Illumina Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Hologic Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Almac Group Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Janssen Global Services Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Sysmex Corporation Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
